Complete remission of advanced hepatocellular carcinoma by sorafenib: A case report

doi:10.4251/wjgo.v5.i2.38

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5725)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

456

HTML

2737

Figures (1-3)

521

Sum=3714

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1125

Download

886

Sum=2011

Feb 15, 2013 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastrointest Oncol. Feb 15, 2013; 5(2): 38-42
Published online Feb 15, 2013. doi: 10.4251/wjgo.v5.i2.38

Full Size Figure Download Figure

Figure 3 Positron emission tomography computed tomography. A, B: After four sessions of transarterial chemoembolization, significant multiple abdominal lymphadenopathy was detected by positron emission tomography (PET)-computed tomography (CT) (black arrows); C, D: Fluorine-18 2-fluoro-2-deoxy-D-glucose uptakes disappeared on follow up PET-CT scans taken after 6 mo on sorafenib.

Citation: Kim MS, Jin YJ, Lee JW, Lee JI, Kim YS, Lee SY, Chae MH. Complete remission of advanced hepatocellular carcinoma by sorafenib: A case report. World J Gastrointest Oncol 2013; 5(2): 38-42
URL: https://www.wjgnet.com/1948-5204/full/v5/i2/38.htm
DOI: https://dx.doi.org/10.4251/wjgo.v5.i2.38